FAM111A and glioma: As shown in Figure 3, high expression of FAM111A predicted a remarkably shorter overall survival (OS) both in CGGA (Figures 4A–C) and in TCGA datasets (Figures 4D–F) in LGGs, which included WHO grade II and WHO grade III gliomas.